TY - JOUR
T1 - Differential characteristics of cytotoxic T lymphocytes restricted by the protective HLA alleles B∗27 and B∗57 in HIV-1 infection
AU - Schellens, Ingrid M.M.
AU - Spits, Hilde B.
AU - Navis, Marjon
AU - Westerlaken, Geertje H.A.
AU - Nanlohy, Nening M.
AU - Coffeng, Luc E.
AU - Kootstra, Neeltje
AU - Miedema, Frank
AU - Schuitemaker, Hanneke
AU - Borghans, José A.M.
AU - Van Baarle, Debbie
N1 - Publisher Copyright:
Copyright © 2014 by Lippincott Williams & Wilkins.
PY - 2014
Y1 - 2014
N2 - Objective: HLA-B∗27 and B∗57 are associated with relatively slow progression to AIDS. Mechanisms held responsible for this protective effect include the immunodominance and high magnitude, breadth, and affinity of the cytotoxic T lymphocytes (CTL) response restricted by these HLA molecules, as well as superior maintenance of CTL responses during HIV-1 disease progression. Design: We examined CTL responses from HIV-1-infected individuals restricted through protective and nonprotective HLA alleles within the same host, thereby excluding any effects of slow or rapid progression on the CTL response. Results: We found that neither immunodominance, nor high magnitude and breadth, nor affinity of the CTL response are general mechanisms of protection against disease progression. HLA-B∗57-restricted CTL responses were of exceptionally high affinity and dominated the HLA-A∗02-restricted CTL response in individuals coexpressing these HLA alleles. In contrast, HLA-B∗27-restricted CTL responses were not of particularly high affinity and did not dominate the response in individuals coexpressing HLA-B∗27 and HLA-A∗02. Instead, in individuals expressing HLA-B∗27, the CTL response restricted by nonprotective HLA alleles was significantly higher and broader, and of higher affinity than in individuals expressing these alleles without HLA-B∗27. Although HLA-B∗27 and B∗57 are thought to target the most conserved parts of HIV, during disease progression, CTL responses restricted by HLA-B∗27 and B∗57 were lost at least as fast as CTL responses restricted by HLA-A∗02. Conclusions: Our data show that many of the mechanisms of CTL that are generally held responsible for slowing down HIV-1 disease progression hold for HLA-B∗57 but do not hold for HLA-B∗27.
AB - Objective: HLA-B∗27 and B∗57 are associated with relatively slow progression to AIDS. Mechanisms held responsible for this protective effect include the immunodominance and high magnitude, breadth, and affinity of the cytotoxic T lymphocytes (CTL) response restricted by these HLA molecules, as well as superior maintenance of CTL responses during HIV-1 disease progression. Design: We examined CTL responses from HIV-1-infected individuals restricted through protective and nonprotective HLA alleles within the same host, thereby excluding any effects of slow or rapid progression on the CTL response. Results: We found that neither immunodominance, nor high magnitude and breadth, nor affinity of the CTL response are general mechanisms of protection against disease progression. HLA-B∗57-restricted CTL responses were of exceptionally high affinity and dominated the HLA-A∗02-restricted CTL response in individuals coexpressing these HLA alleles. In contrast, HLA-B∗27-restricted CTL responses were not of particularly high affinity and did not dominate the response in individuals coexpressing HLA-B∗27 and HLA-A∗02. Instead, in individuals expressing HLA-B∗27, the CTL response restricted by nonprotective HLA alleles was significantly higher and broader, and of higher affinity than in individuals expressing these alleles without HLA-B∗27. Although HLA-B∗27 and B∗57 are thought to target the most conserved parts of HIV, during disease progression, CTL responses restricted by HLA-B∗27 and B∗57 were lost at least as fast as CTL responses restricted by HLA-A∗02. Conclusions: Our data show that many of the mechanisms of CTL that are generally held responsible for slowing down HIV-1 disease progression hold for HLA-B∗57 but do not hold for HLA-B∗27.
UR - http://www.scopus.com/inward/record.url?scp=84922069539&partnerID=8YFLogxK
U2 - 10.1097/QAI.0000000000000324
DO - 10.1097/QAI.0000000000000324
M3 - Article
C2 - 25171732
AN - SCOPUS:84922069539
SN - 1525-4135
VL - 67
SP - 236
EP - 245
JO - Journal of Acquired Immune Deficiency Syndromes
JF - Journal of Acquired Immune Deficiency Syndromes
IS - 3
ER -